Education
About Us
Working with TipRanks
Follow Us
Apyx Medical (APYX)
:APYX
APYX Stock Chart & Stats
$3.13
-$0.11(-6.43%)
At close: 4:00 PM EST
$3.13
-$0.11(-6.43%)
Day’s Range― - ―
52-Week Range$0.76 - $4.25
Previous CloseN/A
Volume28.06K
Average Volume (3M)131.11K
Market Cap
$148.00M
Enterprise Value$101.51M
Total Cash (Recent Filing)$25.14M
Total Debt (Recent Filing)$39.21M
Price to Earnings (P/E)―
Beta2.20
Next Earnings
Mar 12, 2026EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding38,241,905
10 Day Avg. Volume96,663
30 Day Avg. Volume131,110
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)3.95
Price to Sales (P/S)1.17
P/FCF Ratio-2.99
Enterprise Value/Market Cap0.69
Enterprise Value/Revenue2.12
Enterprise Value/Gross Profit3.38
Enterprise Value/Ebitda-12.31
Forecast
1Y Price Target
$4.00Price Target Upside27.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Commercial RolloutApyx moved into a full nationwide commercial rollout in September following a successful soft launch this summer with 'overwhelmingly positive' feedback from early adopters.
Patient DemandDr. Vanek added that Ayon allows for broader patient selection and is already driving an increase in patient demand at his practice.
Sales GuidancePre-ordering activity for Ayon exceeded internal expectations, leading to a raised full-year sales guidance.
Bears Say
Apyx Medical News
APYX FAQ
What was Apyx Medical’s price range in the past 12 months?
Apyx Medical lowest stock price was $0.76 and its highest was $4.25 in the past 12 months.
What is Apyx Medical’s market cap?
Apyx Medical’s market cap is $148.00M.
When is Apyx Medical’s upcoming earnings report date?
Apyx Medical’s upcoming earnings report date is Mar 12, 2026 which is in 120 days.
How were Apyx Medical’s earnings last quarter?
Apyx Medical released its earnings results on Nov 06, 2025. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.102 by $0.052.
Is Apyx Medical overvalued?
According to Wall Street analysts Apyx Medical’s price is currently Undervalued.
Does Apyx Medical pay dividends?
Apyx Medical does not currently pay dividends.
What is Apyx Medical’s EPS estimate?
Apyx Medical’s EPS estimate is -0.06.
How many shares outstanding does Apyx Medical have?
Apyx Medical has 38,241,905 shares outstanding.
What happened to Apyx Medical’s price movement after its last earnings report?
Apyx Medical reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.102. Following the earnings report the stock price went up 6.688%.
Which hedge fund is a major shareholder of Apyx Medical?
Currently, no hedge funds are holding shares in APYX
Apyx Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (27.80% Upside)
$4.00 (27.80% Upside)
Hedge Fund Trend
Decreased
By 70.8K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
169.73%
12-Months-Change
Fundamentals
Return on Equity
-172.18%
Trailing 12-Months
Asset Growth
-5.53%
Trailing 12-Months
Company Description
Apyx Medical
Apyx Medical Corporation is a medical technology company focused on developing and commercializing innovative products for the surgical and aesthetic markets. The company specializes in advanced energy-based devices, particularly those utilizing its proprietary Renuvion technology, which combines helium plasma and radiofrequency energy for precision in soft tissue and skin procedures. Apyx Medical serves a diverse range of healthcare providers, including plastic surgeons, dermatologists, and other medical professionals, aiming to enhance patient outcomes and improve the overall efficiency of surgical procedures.
APYX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong focus on the successful launch and market acceptance of the AYON Body Contouring System, with substantial revenue growth in the Surgical Aesthetics segment. Despite declines in OEM revenue and international sales, the company's strategic focus on AYON and improved financial health contribute to a positive outlook.View all APYX earnings summariesAPYX Stock 12 Month Forecast
Average Price Target
$4.00
▲(27.80% Upside)
Technical Analysis
Ownership Overview
1.58%
Insiders
9.37% Mutual Funds
2.86% Other Institutional Investors
82.54% Public Companies and
Individual Investors